Raymond E. Galinsky

1.7k total citations
66 papers, 1.4k citations indexed

About

Raymond E. Galinsky is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Raymond E. Galinsky has authored 66 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pharmacology, 17 papers in Oncology and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Raymond E. Galinsky's work include Drug-Induced Hepatotoxicity and Protection (23 papers), Pharmacogenetics and Drug Metabolism (21 papers) and Drug Transport and Resistance Mechanisms (15 papers). Raymond E. Galinsky is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (23 papers), Pharmacogenetics and Drug Metabolism (21 papers) and Drug Transport and Resistance Mechanisms (15 papers). Raymond E. Galinsky collaborates with scholars based in United States, South Korea and Puerto Rico. Raymond E. Galinsky's co-authors include Gerhard Levy, G Lévy, Barbara L. Hoesterey, Stephen D. Hall, Kang Moo Huh, Sang Cheon Lee, Jaehwi Lee, Kinam Park, Yong Woo Cho and Robert E. Kane and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Immunology and Hepatology.

In The Last Decade

Raymond E. Galinsky

66 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raymond E. Galinsky United States 21 462 299 262 164 158 66 1.4k
Fusao Komada Japan 21 248 0.5× 309 1.0× 391 1.5× 133 0.8× 89 0.6× 67 1.3k
Oliver Yoa‐Pu Hu Taiwan 24 355 0.8× 195 0.7× 305 1.2× 138 0.8× 155 1.0× 86 1.7k
C. Cederberg Sweden 28 388 0.8× 345 1.2× 359 1.4× 197 1.2× 235 1.5× 54 3.5k
Jianghong Fan United States 20 307 0.7× 357 1.2× 423 1.6× 195 1.2× 112 0.7× 45 1.5k
Hiroyasu Ogata Japan 24 307 0.7× 432 1.4× 259 1.0× 245 1.5× 177 1.1× 100 1.7k
Robert P. Clement United States 23 373 0.8× 548 1.8× 342 1.3× 256 1.6× 195 1.2× 35 1.5k
Wolfgang Jacobsen United States 24 518 1.1× 566 1.9× 340 1.3× 485 3.0× 186 1.2× 37 2.3k
Pankaj B. Desai United States 29 545 1.2× 657 2.2× 715 2.7× 248 1.5× 143 0.9× 81 3.1k
Nuala A. Helsby New Zealand 26 522 1.1× 382 1.3× 719 2.7× 169 1.0× 179 1.1× 81 2.0k
John K. Fallon United States 25 484 1.0× 581 1.9× 607 2.3× 258 1.6× 97 0.6× 68 1.9k

Countries citing papers authored by Raymond E. Galinsky

Since Specialization
Citations

This map shows the geographic impact of Raymond E. Galinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond E. Galinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond E. Galinsky more than expected).

Fields of papers citing papers by Raymond E. Galinsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond E. Galinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond E. Galinsky. The network helps show where Raymond E. Galinsky may publish in the future.

Co-authorship network of co-authors of Raymond E. Galinsky

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond E. Galinsky. A scholar is included among the top collaborators of Raymond E. Galinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond E. Galinsky. Raymond E. Galinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metzger, Ingrid F., et al.. (2019). CYP2B6 Genotype‐Dependent Inhibition of CYP1A2 and Induction of CYP2A6 by the Antiretroviral Drug Efavirenz in Healthy Volunteers. Clinical and Translational Science. 12(6). 657–666. 10 indexed citations
2.
Quinney, Sara K., Raymond E. Galinsky, Yong Chen, et al.. (2008). Hydroxyitraconazole, Formed During Intestinal First-Pass Metabolism of Itraconazole, Controls the Time Course of Hepatic CYP3A Inhibition and the Bioavailability of Itraconazole in Rats. Drug Metabolism and Disposition. 36(6). 1097–1101. 25 indexed citations
3.
Morrow, Jason D., Timi Edeki, Mohamed El Mouelhi, et al.. (2005). American Society for Clinical Pharmacology and Therapeutics Position Statement on Dietary Supplement Safety and Regulation*. Clinical Pharmacology & Therapeutics. 77(3). 113–122. 20 indexed citations
4.
Pu, Xinzhu, Linda Lee, Raymond E. Galinsky, & Gary P. Carlson. (2005). Bioavailability of 2,3′,4,4′,5-pentachlorobiphenyl (PCB118) and 2,2′,5,5′-tetrachlorobiphenyl (PCB52) from soils using a rat model and a physiologically based extraction test. Toxicology. 217(1). 14–21. 32 indexed citations
5.
Galinsky, Raymond E., et al.. (2000). Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma. Pharmacogenetics. 10(3). 261–266. 75 indexed citations
6.
Raftogianis, Rebecca B., Michael R. Franklin, & Raymond E. Galinsky. (1995). The Depression of Hepatic Drug Conjugation Reactions in Rats After Lipid‐Free Total Parenteral Nutrition Administered via the Portal Vein. Journal of Parenteral and Enteral Nutrition. 19(4). 303–309. 3 indexed citations
7.
Bonkovsky, Herbert L., Robert E. Kane, Dean P. Jones, Raymond E. Galinsky, & Barbara F. Banner. (1994). Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: Evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency. Hepatology. 19(5). 1141–1148. 70 indexed citations
8.
Kimura, Robert E., et al.. (1993). Age-related changes in homeostasis on inorganic sulfate in male F-344 rats. Mechanisms of Ageing and Development. 66(3). 257–267. 12 indexed citations
9.
Anderson, Bradley D., Raymond E. Galinsky, David C. Baker, et al.. (1992). Approaches toward the optimization of CNS uptake of anti-AIDS agents. Journal of Controlled Release. 19(1-3). 219–229. 19 indexed citations
10.
Galinsky, Raymond E. & Nancy A. Nickman. (1991). Pharmacists and the Mandate of Pharmaceutical Care. DICP. 25(4). 431–434. 4 indexed citations
11.
Hoesterey, Barbara L., Raymond E. Galinsky, & Brian D. O. Anderson. (1991). Dose dependence in the plasma pharmacokinetics and uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats.. Drug Metabolism and Disposition. 19(5). 907–912. 15 indexed citations
12.
Anderson, Brian D. O., et al.. (1990). Uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats: intravenous infusion studies.. Journal of Pharmacology and Experimental Therapeutics. 253(1). 113–118. 50 indexed citations
13.
Galinsky, Raymond E., Barbara L. Hoesterey, & Bradley D. Anderson. (1990). Brain and cerebrospinal fluid uptake of zidovudine (AZT) in rats after intravenous injection. Life Sciences. 47(9). 781–788. 39 indexed citations
14.
Galinsky, Raymond E., Donald H. Johnson, Robert E. Kane, & M R Franklin. (1990). Effect of aging on hepatic biotransformation in female Fischer 344 rats: changes in sulfotransferase activities are consistent with known gender-related changes in pituitary growth hormone secretion in aging animals.. Journal of Pharmacology and Experimental Therapeutics. 255(2). 577–583. 13 indexed citations
15.
Galinsky, Raymond E., et al.. (1990). Effect on advanced age on p-aminohippurate-induced inhibition of renal tubular secretion in male fischer 344 rats. Mechanisms of Ageing and Development. 56(3). 209–222. 4 indexed citations
16.
Anderson, Bradley D., Barbara L. Hoesterey, David C. Baker, & Raymond E. Galinsky. (1990). Kinetics of ddI in Plasma, Brain, and CSF of Rats after Administration of ddI and an Ester Prodrug of ddIa. Annals of the New York Academy of Sciences. 616(1). 472–474. 6 indexed citations
17.
Galinsky, Raymond E. & George B. Corcoran. (1988). Suppression of acetaminophen conjugation and of conjugate elimination in the rat by metyrapone, a classical P-450 inhibitor.. Drug Metabolism and Disposition. 16(3). 348–354. 3 indexed citations
18.
Galinsky, Raymond E., et al.. (1988). Effect of Taurolithocholate on In Vivo Sulfation and Glucuronidation of Acetaminophen in Rats. Pharmaceutical Research. 5(1). 61–64. 5 indexed citations
19.
Lemaigre, G, et al.. (1975). Hépatite fulminante par intoxication due au chardon à glu (Atractylis gummifera-L). Etude anatomo-pathologique de 4 cas. ˜La œNouvelle presse médicale. 4(40). 8 indexed citations
20.
Lemaigre, G, et al.. (1975). [Fulminating hepatitis caused by glue thistle (Atractylis glummifera-L.), poisoning. Anatomo-pathological study of 4 cases].. PubMed. 4(40). 2565–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026